Global SUS (Single Use System) for Biopharma Process Market Growth (Status and Outlook) 2023-2029

Global SUS (Single Use System) for Biopharma Process Market Growth (Status and Outlook) 2023-2029

Single-use systems (SUS) refers to biopharmaceutical manufacturing (bioprocessing) equipment designed to be used once (or for a single manufacturing campaign) and then discarded.
LPI (LP Information)' newest research report, the “SUS (Single Use System) for Biopharma Process Industry Forecast” looks at past sales and reviews total world SUS (Single Use System) for Biopharma Process sales in 2022, providing a comprehensive analysis by region and market sector of projected SUS (Single Use System) for Biopharma Process sales for 2023 through 2029. With SUS (Single Use System) for Biopharma Process sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world SUS (Single Use System) for Biopharma Process industry.
This Insight Report provides a comprehensive analysis of the global SUS (Single Use System) for Biopharma Process landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on SUS (Single Use System) for Biopharma Process portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global SUS (Single Use System) for Biopharma Process market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for SUS (Single Use System) for Biopharma Process and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global SUS (Single Use System) for Biopharma Process.
The global SUS (Single Use System) for Biopharma Process market size is projected to grow from US$ 4383.1 million in 2022 to US$ 15780 million in 2029; it is expected to grow at a CAGR of 20.1% from 2023 to 2029.
Global key players of SUS (single use system) for biopharma process include Danaher, Thermo Fisher, Sartorius, Merck, Lepure China, etc. The top five players hold a share about 73%. North America and Europe are the two largest markets, both has a share about 32%, followed by Asia-Pacific, with share 31%.
This report presents a comprehensive overview, market shares, and growth opportunities of SUS (Single Use System) for Biopharma Process market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Single-use Bioreactor
Disposable Sterile Bags
Disposable Filtration System
Other
Segmentation by application
Bio-pharmacy
CDMO
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
SATAKE MultiMix
Danaher
Thermo Fisher
Sartorius
Merck
Lepure China
JYSS Bio-Engineering
Tofflon
Duoning Biotechnology
ABEC
AUSTAR

Please note: The report will take approximately 2 business days to prepare and deliver.